Skip to main content

April 2014

Crack GPAT — Prepare for GPAT Online 

New drug approved for treating psoriatic arthritis by FDA

The U.S. Food and Drug Administration approved Otezla (apremilast), manufactured for Celgene Corporation, Summit, N.J.,  to treat adults with active psoriatic arthritis (PsA), which is a form of arthritis that affects some people with psoriasis. Most people develop psoriasis first and are later diagnosed with PsA. Joint pain, stiffness and swelling are the main signs and symptoms of PsA.

HIV-positive men at higher risk for Heart Disease

Formation of plaques is more frequent in coronary arteries of HIV positive men than HIV negative men, according to a new study by National Institutes of Health grantees. The research describes that HIV-infected men are at higher risk for a heart attack than their HIV-uninfected which is published in Annals of Internal Medicine.

Conference on Good Clinical Practice organized by Infectious Diseases Department, Maharashtra University of Health Sciences, Nashik

The Main objective of establishing this Health Sciences University is to ensure proper and systematic instruction, teaching, training and research in modern medicine and the Indian system of Medicine in the State of Maharashtra and to have a balanced growth in the medical sciences.

Career for Asst. Development Manager @ Unilever

Every day, around the world, people reach for Unilever products. Our brands are trusted everywhere and, by listening to the people who buy them, we've grown into one of the world's most successful consumer goods companies. In fact, 150 million times a day, someone somewhere chooses a Unilever product.
Look in your fridge, or on the bathroom shelf, and you’re bound to see one of our well-known brands. We create, market and distribute the products that people choose to feed their families and keep themselves and their homes clean and fresh.

Post: Asst. Development Manager( Job Number: 1400079A)

Programmes for M.Sc , Ph.D in bioinformatics at Central University Of Bihar Entrance Test | B.Pharm, M.Pharm eligible

The Central University of Bihar (CUB) is one among the sixteen newly established Central Universities by the Government of India under the Central Universities Act, 2009 (Section 25 of 2009). The University is presently located at the premises of Birla Institute of Technology, Patna (BIT Campus, P.O.- B. V. College, Patna– 800 014). The University is most likely to be located at Panchanpur, approximately 10 km from Gaya on Defence land to be transferred soon. Keeping in view of the permanent location of the University at Gaya, it has been decided to launch new academic Programmes at Gaya.

Online/offline applications are invited in the prescribed form from eligible candidates for admission to the following Academic Programmes in Central University of Bihar for the Academic Year 2014-15.

Opportunity for Research Careers in Science & Technology as (Scientist and Senior Scientist) in IIP - Multiple vacancies

CSIR-Indian Institute of Petroleum, Dehradun, a premier institute under the Council of Scientific and Industrial Research (CSIR), is involved in multidisciplinary R&D programmes of both basic and applied nature across scientific disciplines for economic, environmental and societal benefits for the people of India. CSIR-IIP has a rich legacy of being a pioneer in the area of Petroleum & Hydrocarbon industry and is presently engaged in the development of sophisticated green technologies to cater to the energy needs of modern world and for reducing carbon footprint.

CSIR-IIP has developed and transferred technologies to industries in the area of petroleum refining, natural gas, petrochemicals, chemicals and utilisation of petroleum products, provided technical services and imparted world class training to the human resource of Oil and Refining industry. CSIR-IIP has strong international collaborations with industries and academia in India & abroad and has outstanding scientist in the multidisciplinary areas of R&D in the hydrocarbon and related industry.